HomeNews & TopicsInfection ControlStudy helps explain vaccination rates and vaccine hesitancy

Study helps explain vaccination rates and vaccine hesitancy

Published on

The iCARE survey of public attitudes around COVID-19 has finished its 12th round of data-gathering since its launch in March 2020  

By Patrick Lejtenyi

A Montreal-led international survey of global attitudes around the COVID-19 pandemic is taking a close look at what drives people to vaccinate themselves against the virus and what motivates those who are still avoiding it.

“The largest drivers behind people getting vaccinated are all altruistic,” says Simon Bacon, professor of health, kinesiology and applied physiology in Concordia’s Faculty of Arts and Science and one of the survey’s principal investigators.

“There is a feeling that they are doing the right thing, that getting vaccinated is good for the general populace. In contrast, those who are unvaccinated are more concerned about the vaccine’s safety and efficacy and whether vaccination will allow them to go to events. It becomes more about how the vaccine affects them as a person.”

The data shows that coercive methods to increase vaccination rates, such as vaccine passports, are generally popular in Canada, with around 70 per cent of the population supporting them. However, they may not be as effective at boosting vaccination rates as some would hope: they do nothing to counter fears that the vaccine is either ineffective or unsafe. Early reports of serious side effects such as blood clots also undermined confidence in the vaccines in some respondents.

A spectrum of resistance 

The unvaccinated are by no means a homogeneous group.

“We have to disentangle the difference between those who are vaccine hesitant and those who are vaccine resistant,” he says. “Just less than 10 per cent of the population is vaccine resistant, meaning that almost nothing will change their minds about getting vaccinated. Another group, between 15 to 25 per cent of the population depending on the country, is not necessarily against the vaccine but does have some concern, usually driven around fears of efficacy and safety, or issues around access.”

This group, the data shows, tends to skew toward being female and younger, to have reported financial or mental-health difficulties resulting from the pandemic and identify as being from traditionally underrepresented groups.

“It’s a bit confounding, because we know that historically, underrepresented groups tend to have greater distrust in the health-care system in general. But those groups also tend to be from a lower socioeconomic status. It may not be their beliefs about the vaccine that is preventing them from getting a shot; it may be more practical issues.”

Bacon says the researchers have adapted their questionnaire to better identify those who are hesitant from those who are deeply resistant.

 

An ongoing study 

Bacon and Lavoie launched the iCARE (International COVID-19 Awareness and Responses Evaluation) study in March 2020, just as most countries were implementing their lockdowns. Over the past 18 months, the study has examined public attitudes toward government and institutional responses to the pandemic, the effectiveness of the communication of government and health authorities’ directives, personal feelings of anxiety, weight gain or loss, consumption of alcohol, tobacco and drugs and more. It has just completed its 12th cycle of data gathering.

The iCARE project is being conducted by the Montreal Behavioural Medicine Centre (MBMC), a joint Concordia / UQAM / CIUSSS du Nord-de-l’Île-de-Montréal academic research and training centre the pair founded in 2006. Some 200 researchers across 40 countries are collaborating on the project.

The 20-minute survey is available in almost 40 languages and to date, approximately 100,000 people from 175 countries have completed it. Its latest version is now available on the MBMC website.

iCARE is supported by the Canadian Institutes of Health Research, the Fonds de recherche du Québec ­­–Santé and the Fonds de recherche du Québec – Société et culture. Study sponsors had no role in the design of the database and data collection.  

Patrick Lejtenyi is an Advisor, Public Affairs at Concordia University.

 

Latest articles

New approach opens door to better-targeted treatments and faster drug discovery for complex diseases

McGill researchers have developed an AI tool called SIDISH that identifies high-risk cancer cells driving aggressive disease, enabling more precise and targeted treatment strategies. By linking single-cell data with patient outcomes, the tool can predict disease progression and simulate responses to potential drug targets, helping accelerate drug discovery and repurposing. While still in development, SIDISH shows promise for advancing personalized cancer care and improving outcomes across multiple tumour types.

Canadian Cancer Society urges lowering colorectal cancer screening age to 45

The Canadian Cancer Society is urging provinces to lower the colorectal cancer screening age from 50 to 45, citing rising rates among younger adults and evidence that earlier screening could prevent over 15,000 cases and 6,100 deaths. Younger patients are more often diagnosed at advanced stages, making early detection critical. Expanding access to simple screening tools like FIT tests could significantly improve outcomes and save lives.

Unleashing natural killer cells against cancer

Researchers at McGill University have developed a new strategy to enhance natural killer (NK) cells, enabling them to better penetrate tumour defenses and destroy cancer cells. Using small-molecule drugs to temporarily boost NK cell activity—rather than permanent genetic modification—the approach showed strong results against multiple hard-to-treat cancers in preclinical studies. The scalable, ready-to-use therapy could make immunotherapy faster, safer, and more accessible, with future clinical trials planned for aggressive cancers like acute myeloid leukemia.

Doctors report false health information, lack of health data sharing put patient care at risk

A new CMA survey reveals major risks to patient care in Canada, with 99% of physicians reporting that disconnected health systems limit access to critical patient information and nearly half witnessing serious adverse outcomes as a result. At the same time, 97% of doctors say they have intervened to address harm caused by false or misleading online health information, including AI-generated advice. The findings highlight the urgent need for integrated digital health systems and stronger efforts to promote reliable health information.

More like this

From injection to ingestion: Can yeast make vaccines more accessible?

HN Summary • Oral Yeast-Based Vaccines: Researchers, including Emilija Vasiliunaité at Vilnius University Life Sciences...

Smarter tissue and organ repair thanks to next-gen hydrogel

HN Summary • uOttawa multidisciplinary team has built new hydrogels from synthetic peptides that can...

Antibiotic resistance in Canada: What you can do

It’s normal to want quick relief when you’re sick fighting an infection. Antibiotics seem...

Chikungunya cases increasing in several countries in the Americas; PAHO recommends preparedness

HN Summary • Pan American Health Organization (PAHO) has issued an epidemiological alert due to...

Beyond the bedside: The silent safeguard of the operating room

HN Summary • Medical Device Reprocessing Departments at St. Paul’s and Mount Saint Joseph hospitals...

Rethinking access control in healthcare: Infection prevention meets security

Infection prevention has always been a cornerstone of healthcare, but recent years have brought...